Insurance startup Oscar hires CCO from Advisory Board

John Gregory | August 04, 2017 | Health Exec | Management

Oscar Insurance, a startup insurer specializing in narrow network plans offered on the Affordable Care Act (ACA) exchanges, has hired Dennis Weaver, MD, MBA, as its new chief clinical officer (CCO).

As Bloomberg reports, Weaver was previously chief medical officer (CMO) at health consultant Advisory Board. Past roles include president and CEO of EastPoint Health in Overland Park, Kan. and associate CMO and Medicare coordinator at Minnesota-based TriCare.

“Dennis’s extensive experience working with providers and health systems helping them transition to population health more aggressively will also be instrumental as we look to expand and partner closely with health systems,” Oscar CEO Mario Schlosser said.

Weaver leaves Advisory Board as the company’s healthcare division is rumored to be up for sale, potentially fetching $1.5 billion.

Read the full article at the link below:

Obamacare Startup Oscar Hires Clinical Chief for Care Push

John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular Business

Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.

Cardiovascular Business

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business

FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.

Insurance startup Oscar hires CCO from Advisory Board

Related Content

Around the web